Basic Information
| RNALocate ID: | RLID:01001553 |
| RNA Symbol: | hsa-miR-196a-5p |
| Localization: | Nucleus |
RNA Information
| RNA Name: | hsa-miR-196a |
| RNA ID: | miRBase:MIMAT0000226 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 20498841 |
| Tissue/Cell Line: | Nasopharyngeal carcinoma cells |
| Method: | Next-generation RNA sequencing |
| Description: | The expression level of all microRNAs that detected in the nuclear and cytoplasmic 18-30nt sRNA of 293T cell line. Table S5. The N/C values of all isomiRs. The isomiRs are shown only if it displayed a raw read count (non-normalized) more than 10 in at least one library. Data are collected from Table S5, S9. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001548 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001549 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001550 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001551 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001552 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11001257 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
| RLID:11001258 | Exosome | Serum | 18589210 |
| RLID:11001259 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11001260 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11001261 | Exosome | Brain tissue | 23382797 |
| RLID:11001262 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11001263 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000037 | Exosome | Colon tissue|Tongue tissue | |
| RLID-D:11000305 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-196a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-23970 |
| MNDR | hsa-miR-196a-5p | Oral squamous cell carcinoma | MNDR-E-MI-23971 |
| MNDR | hsa-miR-196a-5p | Large cell neuroendocrine cancer | MNDR-E-MI-23972 |
| MNDR | hsa-miR-196a-5p | Follicular cleaved lymphoma | MNDR-E-MI-23973 |
| MNDR | hsa-miR-196a-5p | Lymphoma | MNDR-E-MI-23974 |
| MNDR | hsa-miR-196a-5p | Non-hodgkin lymphoma | MNDR-E-MI-23975 |
| MNDR | hsa-miR-196a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-23976 |
| MNDR | hsa-miR-196a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-23977 |
| MNDR | hsa-miR-196a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-23978 |
| MNDR | hsa-miR-196a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-23979 |
| MNDR | hsa-miR-196a-5p | Breast cancer luminal | MNDR-E-MI-23980 |
| MNDR | hsa-miR-196a-5p | Niemann-pick disease type c | MNDR-E-MI-23981 |
| MNDR | hsa-miR-196a-5p | Small intestine cancer | MNDR-E-MI-23982 |
| MNDR | hsa-miR-196a-5p | Prostate cancer | MNDR-E-MI-23983 |
| MNDR | hsa-miR-196a-5p | Chronic lymphocytic leukemia | MNDR-E-MI-23984 |
| MNDR | hsa-miR-196a-5p | Gastric cancer | MNDR-E-MI-23985 |
| MNDR | hsa-miR-196a-5p | Adrenoleukodystrophy | MNDR-E-MI-23986 |
| MNDR | hsa-miR-196a-5p | Intracranial aneurysm | MNDR-E-MI-23987 |
| MNDR | hsa-miR-196a-5p | Esophageal carcinoma | MNDR-E-MI-23988 |
| MNDR | hsa-miR-196a-5p | Heart disease | MNDR-E-MI-23989 |
| MNDR | hsa-miR-196a-5p | Head and neck cancer | MNDR-E-MI-23990 |
| MNDR | hsa-miR-196a-5p | Vitiligo | MNDR-E-MI-23991 |
| MNDR | hsa-miR-196a-5p | Leukemia | MNDR-E-MI-23992 |
| MNDR | hsa-miR-196a-5p | Acute leukemia | MNDR-E-MI-23993 |
| MNDR | hsa-miR-196a-5p | Huntington disease | MNDR-E-MI-23994 |
| MNDR | hsa-miR-196a-5p | Chorea | MNDR-E-MI-23995 |
| MNDR | hsa-miR-196a-5p | Lung cancer | MNDR-E-MI-23996 |
| MNDR | hsa-miR-196a-5p | Down syndrome | MNDR-E-MI-23997 |
| MNDR | hsa-miR-196a-5p | Parkinson disease | MNDR-E-MI-23998 |
| MNDR | hsa-miR-196a-5p | Niemann-pick disease | MNDR-E-MI-23999 |
| MNDR | hsa-miR-196a-5p | Breast cancer | MNDR-E-MI-24000 |
| MNDR | hsa-miR-196a-5p | Congenital heart disease | MNDR-E-MI-24001 |
| MNDR | hsa-miR-196a-5p | Neuroendocrine neoplasia | MNDR-E-MI-24002 |
| MNDR | hsa-miR-196a-5p | Pancreatic cancer | MNDR-E-MI-24003 |
| MNDR | hsa-miR-196a-5p | Pancreatic endocrine carcinoma | MNDR-E-MI-24004 |
| MNDR | hsa-miR-196a-5p | Malignant melanoma | MNDR-E-MI-24005 |
| MNDR | hsa-miR-196a-5p | Rectum adenocarcinoma | MNDR-E-MI-24006 |
| MNDR | hsa-miR-196a-5p | Colon cancer | MNDR-E-MI-24007 |
| MNDR | hsa-miR-196a-5p | Colon adenocarcinoma | MNDR-E-MI-24008 |
| MNDR | hsa-miR-196a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-24009 |
| MNDR | hsa-miR-196a-5p | Familial ovarian cancer | MNDR-E-MI-24010 |
| MNDR | hsa-miR-196a-5p | Prostate adenocarcinoma | MNDR-E-MI-24011 |
| MNDR | hsa-miR-196a-5p | Endometriosis | MNDR-E-MI-24012 |
| MNDR | hsa-miR-196a-5p | Pulmonary tuberculosis | MNDR-E-MI-24013 |
| MNDR | hsa-miR-196a-5p | Carcinoma ductal breast | MNDR-E-MI-24014 |
| MNDR | hsa-miR-196a-5p | Glioblastoma | MNDR-E-MI-24015 |
| MNDR | hsa-miR-196a-5p | Glioma | MNDR-E-MI-24016 |
| MNDR | hsa-miR-196a-5p | Osteosarcoma | MNDR-E-MI-24017 |
| MNDR | hsa-miR-196a-5p | Breast carcinoma | MNDR-E-MI-24018 |
| MNDR | hsa-miR-196a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-24019 |
| MNDR | hsa-miR-196a-5p | Uterus cancer | MNDR-E-MI-24020 |
| MNDR | hsa-miR-196a-5p | Gastric adenocarcinoma | MNDR-E-MI-24021 |
| MNDR | hsa-miR-196a-5p | Pituitary adenoma | MNDR-E-MI-24022 |
| MNDR | hsa-miR-196a-5p | Lung squamous cell carcinoma | MNDR-E-MI-24023 |
| MNDR | hsa-miR-196a-5p | Non-small cell lung cancer | MNDR-E-MI-24024 |
| MNDR | hsa-miR-196a-5p | Lung adenocarcinoma | MNDR-E-MI-24025 |
| MNDR | hsa-miR-196a-5p | Adrenocortical carcinoma | MNDR-E-MI-24026 |
| MNDR | hsa-miR-196a-5p | Thyroid carcinoma | MNDR-E-MI-24027 |
| MNDR | hsa-miR-196a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-24028 |
| MNDR | hsa-miR-196a-5p | Scleroderma | MNDR-E-MI-24029 |
| MNDR | hsa-miR-196a-5p | Carcinoma renal cell | MNDR-E-MI-24030 |
| MNDR | hsa-miR-196a-5p | Renal clear cell carcinoma | MNDR-E-MI-24031 |
| MNDR | hsa-miR-196a-5p | Biliary tract cancer | MNDR-E-MI-24032 |
| MNDR | hsa-miR-196a-5p | Esophageal adenocarcinoma | MNDR-E-MI-24033 |
| MNDR | hsa-miR-196a-5p | Cholangiocarcinoma | MNDR-E-MI-24034 |
| MNDR | hsa-miR-196a-5p | Esophageal cancer | MNDR-E-MI-24035 |
| MNDR | hsa-miR-196a-5p | Infertility | MNDR-E-MI-24036 |
| MNDR | hsa-miR-196a-5p | Lung small cell carcinoma | MNDR-E-MI-24037 |
| MNDR | hsa-miR-196a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-24038 |
| MNDR | hsa-miR-196a-5p | Testicular germ cell cancer | MNDR-E-MI-24039 |
| MNDR | hsa-miR-196a-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-24040 |
| MNDR | hsa-miR-196a-5p | Breast invasive carcinoma | MNDR-E-MI-24041 |
| MNDR | hsa-miR-196a-5p | Hepatocellular carcinoma | MNDR-E-MI-24042 |
| MNDR | hsa-miR-196a-5p | Embryonal cancer | MNDR-E-MI-24043 |
| MNDR | hsa-miR-196a-5p | Familiar ovarian carcinoma | MNDR-E-MI-24044 |
| MNDR | hsa-miR-196a-5p | B-cell lymphoma | MNDR-E-MI-24045 |
| MNDR | hsa-miR-196a-5p | Retinoblastoma | MNDR-E-MI-24046 |
| MNDR | hsa-miR-196a-5p | Barrett's adenocarcinoma | MNDR-E-MI-24047 |
| MNDR | hsa-miR-196a-5p | Hodgkin lymphoma | MNDR-E-MI-24048 |
| MNDR | hsa-miR-196a-5p | Mouth neoplasms | MNDR-E-MI-24049 |
| MNDR | hsa-miR-196a-5p | Crohn disease | MNDR-E-MI-24050 |
| MNDR | hsa-miR-196a-5p | Tonsil cancer | MNDR-E-MI-24051 |
| MNDR | hsa-miR-196a-5p | Neuromyelitis optica | MNDR-E-MI-24052 |
| MNDR | hsa-miR-196a-5p | Gastrointestinal stromal tumor | MNDR-E-MI-24053 |
| MNDR | hsa-miR-196a-5p | Colorectal cancer | MNDR-E-MI-24054 |
| MNDR | hsa-miR-196a-5p | Type 2 diabetes mellitus | MNDR-E-MI-24055 |
| MNDR | hsa-miR-196a-5p | Multiple myeloma | MNDR-E-MI-24056 |
| MNDR | hsa-miR-196a-5p | Ependymoma | MNDR-E-MI-24057 |
| MNDR | hsa-miR-196a-5p | Prostatic neoplasms | MNDR-E-MI-24058 |
| MNDR | hsa-miR-196a-5p | Hypersomnolence idiopathic | MNDR-E-MI-24059 |
| MNDR | hsa-miR-196a-5p | Stroke | MNDR-E-MI-24060 |
| MNDR | hsa-miR-196a-5p | Stroke lacunar | MNDR-E-MI-24061 |
| MNDR | hsa-miR-196a-5p | Barrett's carcinogenesis | MNDR-E-MI-24062 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ANXA1 | Homo sapiens | RR00084307 |
TOP